Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo

Journal of Endocrinology

Volumn 195, Issue 2, 2007, Pages 323-331

  Park, Edward ^a   Wong, Victor ^a   Guan, Xinyu ^a   Oprescu, Andrei I ^a   Giacca, Adria ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; HEPARIN; I KAPPA B ALPHA; I KAPPA B KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTRALIPID; PROTEIN KINASE B; SALICYLATE SODIUM; SERINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVATION; ENZYME INHIBITION; FATTY ACID BLOOD LEVEL; FEMALE; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE UTILIZATION; HORMONE ACTION; HYPERINSULINEMIA; IN VIVO STUDY; INSULIN RESISTANCE; LIVER; LIVER DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; RAT; WISTAR RAT;

ANIMALS; DRUG COMBINATIONS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLYCEROL; I-KAPPA B KINASE; INSULIN; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SERINE; SIGNAL TRANSDUCTION; SODIUM SALICYLATE; TIME FACTORS; TYROSINE;

EID: 36348962971     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/JOE-07-0005     Document Type: Article

References (33)

1. Aguirre V, Uchida T, Yenush L, Davis R & White MF 2000 The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrace-1 and phosphorylation of Ser(307). Journal of Biological Chemistry 275 9047-9054.
2. Altszuler N, De Bodo RC, Steele R & Wall JS 1956 Measurement of size and turnover rate of body glucose pool by the isotope dilution method. American Journal of Physiology 187 15-24.
3. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J & Karin M 2005 IKK-beta links inflammation to obesity-induced insulin resistance. Nature Medicine 11 191-198.
4. Beard KM, Lu H, Ho K & Fantus IG 2006 Bradykinin augments insulin-stimulated glucose transport in rat adipocytes via endothelial nitric oxide synthase-mediated inhibition of Jun NH2-terminal kinase. Diabetes 55 2678-2687.
5. Birnbaum MJ 2001 Turning down insulin signaling. Journal of Clinical Investigation 108 655-659.
6. Boden G 1996 Fatty acids and insulin resistance. Diabetes Care 19 394-395.
7. Boden G, Lebed B, Schatz M, Homko C & Lemieux S 2001 Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50 1612-1617.
8. Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, Xiang X, Luo Z & Ruderman N 2005 Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver. Diabetes 54 3458-3465.
9. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J & Shoelson SE 2005 Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-κB. Nature Medicine 11 183-190.
10. Finegood DT, Bergman RN & Vranic M 1987 Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36 914-924.
11. Finegood DT, Bergman RN & Vranic M 1988 Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 37 1025-1034.
12. Fisher SJ, Shi ZQ, Lickley HL, Efendic S, Vranic M & Giacca A 1996 A moderate decline in specific activity does not lead to an underestimation of hepatic glucose production during a glucose clamp. Metabolism 45 587-593.
13. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ & Ye J 2002 Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. Journal of Biological Chemistry 277 48115-48121.
14. Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M & Ye J 2004 Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Molecular Endocrinology 18 2024-2034.
15. He J, Usui I, Ishizuka K, Kanatani Y, Hiratani K, Iwata M, Bukhari A, Haruta T, Sasaoka T & Kobayashi M 2006 Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes. Molecular Endocrinology 20 114-124.
16. Hotamisligil GS & Spiegelman BM 1994 Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43 1271-1278.
17. Itani SI, Zhou Q, Pories WJ, Macdonald KG & Dohm GL 2000 Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 49 1353-1358.
18. Itani SI, Ruderman NB, Schmieder F & Boden G 2002 Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-alpha. Diabetes 51 2005-2011.
19. Jager J, Gremeaux T, Cormont M, Marchand-Brustel Y & Tanti JF 2007 Interleukin-1 β-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148 241-251.
20. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P et al. 2001 Prevention of fat-induced insulin resistance by salicylate. Journal of Clinical Investigation 108 437-446.
21. Kim HJ, Higashimori T, Park SY, Choi H, Dong J, Kim YJ, Noh HL, Cho YR, Cline G, Kim YB et al. 2004a Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53 1060-1067.
22. Kim JK, Fillmore JJ, Sunshine MJ, Albrecht B, Higashimori T, Kim DW, Liu ZX, Soos TJ, Cline GW, O'Brien WR et al. 2004b PKC-theta knockout mice are protected from fat-induced insulin resistance. Journal of Clinical Investigation 114 823-827.
23. Lam TK, Yoshii H, Haber CA, Bogdanovic E, Lam L, Fantus IG & Giacca A 2002 Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. American Journal of Physiology. Endocrinology and Metabolism 283 E682-E691.
24. Lam TK, van de Werve G & Giacca A 2003 Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. American Journal of Physiology. Endocrinology and Metabolism 284 E281-E290.
25. Peraldi P & Spiegelman B 1998 TNF-alpha and insulin resistance: summary and future prospects. Molecular and Cellular Biochemistry 182 169-175.
26. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW & Shulman GI 1996 Mechanism of free fatty acid-induced insulin resistance in humans. Journal of Clinical Investigation 97 2859-2865.
27. Rotter V, Nagaev I & Smith U 2003 Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells firom insulin-resistant subjects. Journal of Biological Chemistry 278 45777-45784.
28. Scioscia M, Gumaa K, Kunjara S, Paine MA, Selvaggi LE, Rodeck CH & Rademacher TW 2006 Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2. Journal of Clinical Endocrinology and Metabolism 91 709-717.
29. Solinas G, Naugler W, Galimi F, Lee MS & Karin M 2006 Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates, PNAS 103 16454-16459.
30. Wong V, Szeto L, Uffelman K, Fantus IG & Lewis GF 2006 Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway. Journal of Endocrinology 190 441-450.
31. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ et al. 2002 Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. Journal of Biological Chemistry 277 50230-50236.
32. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M & Shoelson SE 2001 Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293 1673-1677.
33. Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF, Xie N, Wilcox D, Jacobson P, Frost L et al. 2002 PTP1B, antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. PNAS 99 11357-11362.